Bingxia Wang

2.3k total citations
56 papers, 1.6k citations indexed

About

Bingxia Wang is a scholar working on Hematology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Bingxia Wang has authored 56 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 18 papers in Molecular Biology and 17 papers in Infectious Diseases. Recurrent topics in Bingxia Wang's work include Multiple Myeloma Research and Treatments (17 papers), HIV/AIDS Research and Interventions (13 papers) and Chronic Lymphocytic Leukemia Research (12 papers). Bingxia Wang is often cited by papers focused on Multiple Myeloma Research and Treatments (17 papers), HIV/AIDS Research and Interventions (13 papers) and Chronic Lymphocytic Leukemia Research (12 papers). Bingxia Wang collaborates with scholars based in United States, Italy and Spain. Bingxia Wang's co-authors include Elena Losina, Kenneth A. Freedberg, Rochelle P. Walensky, Zhigang Lu, Ingrid V. Bassett, Janet Giddy, Matilda Mazibuko, Senica Chetty, Bruce R. Schackman and Robin Wood and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Bingxia Wang

49 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bingxia Wang United States	21	1.0k	675	435	218	194	56	1.6k
Ruth Smith United Kingdom	16	532 0.5×	434 0.6×	203 0.5×	171 0.8×	131 0.7×	23	1.3k
Pasakorn Akarasewi Thailand	24	978 1.0×	958 1.4×	154 0.4×	95 0.4×	165 0.9×	43	1.6k
Amie L. Meditz United States	23	1.0k 1.0×	618 0.9×	1.1k 2.5×	99 0.5×	152 0.8×	33	2.5k
Jeannette Lee United States	16	525 0.5×	245 0.4×	623 1.4×	325 1.5×	70 0.4×	37	1.7k
Lise Cuzin France	27	1.1k 1.1×	688 1.0×	770 1.8×	179 0.8×	71 0.4×	101	1.8k
Alessandro Cozzi Lepri Italy	25	1.1k 1.1×	662 1.0×	844 1.9×	66 0.3×	61 0.3×	70	2.0k
Gregory P. Bisson United States	23	1.4k 1.3×	1000 1.5×	352 0.8×	163 0.7×	73 0.4×	70	1.9k
Clemens Richter Netherlands	21	1.4k 1.4×	851 1.3×	542 1.2×	78 0.4×	207 1.1×	62	2.1k
Danielle Moulia United States	16	788 0.8×	355 0.5×	140 0.3×	162 0.7×	55 0.3×	31	1.4k
Mamta K. Jain United States	24	586 0.6×	1.0k 1.5×	229 0.5×	81 0.4×	102 0.5×	113	1.8k

Countries citing papers authored by Bingxia Wang

Since Specialization

Citations

This map shows the geographic impact of Bingxia Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingxia Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingxia Wang more than expected).

Fields of papers citing papers by Bingxia Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingxia Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingxia Wang. The network helps show where Bingxia Wang may publish in the future.

Co-authorship network of co-authors of Bingxia Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Bingxia Wang. A scholar is included among the top collaborators of Bingxia Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingxia Wang. Bingxia Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tan, Dingyu, Bingxia Wang, Peng Cao, et al.. (2024). High flow nasal cannula oxygen therapy versus non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease with acute-moderate hypercapnic respiratory failure: a randomized controlled non-inferiority trial. Critical Care. 28(1). 250–250. 23 indexed citations

Zhao, R. P., et al.. (2024). A multiple imputation approach in enhancing causal inference for overall survival in randomized controlled trials with crossover. Journal of Biopharmaceutical Statistics. 1–18.

Aldoss, Ibrahim, Josep‐María Ribera, Hagop M. Kantarjian, et al.. (2023). Ponatinib Versus Imatinib in Patients with Newly Diagnosed Ph+ ALL: Subgroup Analysis of the Phase 3 Phallcon Study. Blood. 142(Supplement 1). 2871–2871. 2 indexed citations

Bringhen, Sara, Luděk Pour, Reuben Benjamin, et al.. (2023). Ixazomib Versus Placebo as Postinduction Maintenance Therapy in Newly Diagnosed Multiple Myeloma Patients: An Analysis by Age and Frailty Status of the TOURMALINE-MM4 Study. Clinical Lymphoma Myeloma & Leukemia. 23(7). 491–504. 2 indexed citations

Paiva, Bruno, Irene Manrique, Meletios Α. Dimopoulos, et al.. (2022). MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trials. Blood. 141(6). 579–591. 25 indexed citations

Dudek, Arkadiusz Z., Dejan Juric, Afshin Dowlati, et al.. (2021). 476 First-in-human phase 1/2 study of the first-in-class SUMO-activating enzyme inhibitor TAK-981 in patients with advanced or metastatic solid tumors or relapsed/refractory lymphoma: phase 1 results. Regular and Young Investigator Award Abstracts. A505–A506. 10 indexed citations

Dimopoulos, Meletios Α., Ivan Špıčka, Hang Quach, et al.. (2020). Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial. Journal of Clinical Oncology. 38(34). 4030–4041. 53 indexed citations

Tan, Dingyu, Joseph Harold Walline, Yan Xu, et al.. (2020). High-flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease patients after extubation: a multicenter, randomized controlled trial. Critical Care. 24(1). 489–489. 76 indexed citations

Rifkin, Robert M., Ralph V. Boccia, Suman Kambhampati, et al.. (2017). Tourmaline US-MM6, an Open-Label, Single-Arm, Multicenter Study Evaluating the Effectiveness and Safety of Ixazomib in Combination with Lenalidomide and Dexamethasone (IRd) in Patients (pts) with Newly Diagnosed Multiple Myeloma (NDMM) Switching from a Bortezomib-Based Triplet Induction Regimen. Blood. 130. 5407–5407. 3 indexed citations

10.

Hom, Jeffrey, Bingxia Wang, Senica Chetty, et al.. (2012). Drug-Resistant Tuberculosis among HIV-Infected Patients Starting Antiretroviral Therapy in Durban, South Africa. PLoS ONE. 7(8). e43281–e43281. 6 indexed citations

11.

Wang, Bingxia, Elena Losina, Jennifer Zupkosky, et al.. (2011). Association of IL-10-Promoter Genetic Variants With the Rate of CD4 T-Cell Loss, IL-10 Plasma Levels, and Breadth of Cytotoxic T-Cell Lymphocyte Response During Chronic HIV-1 Infection. Clinical Infectious Diseases. 54(2). 294–302. 18 indexed citations

12.

Wang, Bingxia, Elena Losina, Alison Munro, et al.. (2011). Loss to follow-up in a community clinic in South Africa - roles of gender, pregnancy, and CD4 count. South African Medical Journal. 101(4). 253–253. 63 indexed citations

13.

Bassett, Ingrid V., Senica Chetty, Bingxia Wang, et al.. (2011). Loss to Follow-Up and Mortality Among HIV-Infected People Co-Infected With TB at ART Initiation in Durban, South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 59(1). 25–30. 40 indexed citations

14.

Attarian, Hrayr, Angela Applebee, Bingxia Wang, et al.. (2011). Effect of Eszopiclone on Sleep Disturbances and Daytime Fatigue in Multiple Sclerosis Patients. International Journal of MS Care. 13(2). 84–90. 9 indexed citations

15.

Rydzak, Chara E., Paul E. Sax, Heather Hsu, et al.. (2010). Assessing the Performance of a Computer-Based Policy Model of HIV and AIDS. PLoS ONE. 5(9). e12647–e12647. 23 indexed citations

16.

Paltiel, A. David, Kenneth A. Freedberg, Bruce R. Schackman, et al.. (2009). HIV Preexposure Prophylaxis in the United States: Impact on Lifetime Infection Risk, Clinical Outcomes, and Cost‐Effectiveness. Clinical Infectious Diseases. 48(6). 806–815. 206 indexed citations

17.

Bassett, Ingrid V., Bingxia Wang, Senica Chetty, et al.. (2009). Loss to Care and Death Before Antiretroviral Therapy in Durban, South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 51(2). 135–139. 137 indexed citations

18.

Deuffic‐Burban, Sylvie, Elena Losina, Bingxia Wang, et al.. (2007). Estimates of opportunistic infection incidence or death within specific CD4 strata in HIV-infected patients in Abidjan, Côte d’Ivoire: impact of alternative methods of CD4 count modelling. European Journal of Epidemiology. 22(10). 737–744. 15 indexed citations

19.

Bassett, Ingrid V., Janet Giddy, Bingxia Wang, et al.. (2007). Routine Voluntary HIV Testing in Durban, South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 46(2). 181–186. 81 indexed citations

20.

Bauchner, Howard, Colin D. Marchant, Alice Bisbee, et al.. (2006). Effectiveness of Centers for Disease Control and Prevention Recommendations for Outcomes of Acute Otitis Media. PEDIATRICS. 117(4). 1009–1017. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact